Data / Research funding / End Stage Renal Disease
End Stage Renal Disease: 229 NIH awards ($414.1M) to 90 organizations
229 NIH awards ($414.1M) in the NIH spending category End Stage Renal Disease, to 90 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
229 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $16,391,930 | July 1, 2025 | June 30, 2029 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,843,451 | August 20, 2021 | May 31, 2028 | NAJI, ALI | reporter.nih.gov |
| Targeting the B Cell Response to Treat Antibody-Mediated Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,789,092 | August 20, 2021 | May 31, 2028 | KNECHTLE, STUART JOHNSTON | reporter.nih.gov |
| Advancing Transplantation Outcomes in Children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,293,854 | July 1, 2025 | June 30, 2028 | BRISCOE, DAVID M. | reporter.nih.gov |
| Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,920,671 | September 6, 2021 | June 30, 2028 | BOIKE, JUSTIN | reporter.nih.gov |
| Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,451,589 | September 17, 2021 | August 31, 2027 | FREEDMAN, STEPHEN BRADLEY | reporter.nih.gov |
| A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,767,541 | April 15, 2021 | March 31, 2027 | SCHAUBEL, DOUGLAS EARL | reporter.nih.gov |
| CureGN | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,684,480 | September 16, 2013 | May 31, 2029 | MARIANI, LAURA H | reporter.nih.gov |
| A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial | NIH | National Institute on Aging | 2021 to 2025 | $5,580,574 | September 1, 2021 | August 31, 2027 | MUREA, MARIANA | reporter.nih.gov |
| Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,224,210 | May 25, 2023 | April 30, 2028 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,162,956 | March 25, 2022 | February 28, 2027 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| Safety and efficacy of Belatacept in heart transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,158,955 | June 6, 2023 | March 31, 2028 | HABAL, MARLENA | reporter.nih.gov |
| 14/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Scientific Data Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,865,046 | September 25, 2017 | May 31, 2028 | FREEDMAN, BARRY IRA | reporter.nih.gov |
| Bcl-2 and Mcl-1 inhibition for induction of hematopoietic chimerism and renal allograft tolerance without myelosuppression in nonhuman primates | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,613,595 | June 3, 2022 | May 31, 2027 | KAWAI, TATSUO | reporter.nih.gov |
| Improving Medical Decision Making for Older Patients with End Stage Renal Disease | NIH | National Institute on Aging | 2023 to 2025 | $4,182,158 | April 15, 2020 | March 31, 2027 | PAASCHE-ORLOW, MICHAEL | reporter.nih.gov |
| The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,815,411 | February 1, 2010 | April 30, 2028 | MISRA, SANJAY | reporter.nih.gov |
| Contact Pathway Inhibitor to Prevent Vascular Access Failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,810,461 | June 1, 2023 | March 31, 2027 | LORENTZ, CHRISTINA U | reporter.nih.gov |
| Home Blood Pressure in Hemodialysis (HOME-BP) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,791,550 | May 1, 2021 | April 30, 2027 | BANSAL, NISHA | reporter.nih.gov |
| Clinical Trial to Demonstrate Impact of an AI-enabled 3D Ultrasound-based Guidance System in Reducing Arteriovenous Fistula Cannulation Injury and Improving Patient Quality of Life | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,709,998 | September 15, 2021 | July 31, 2026 | KANG, XIN | reporter.nih.gov |
| Social Determinants of Health, Resilience, and Premature Cognitive Aging in End-stage Renal Disease | NIH | National Institute on Aging | 2022 to 2025 | $3,570,845 | July 15, 2022 | March 31, 2027 | MCADAMS DEMARCO, MARA A. | reporter.nih.gov |
| PERSISTENCE OF IMMUNE RESPONSES TO THE RECOMBINANT ZOSTER VACCINE IN IMMUNE COMPROMISED HOSTS WITH END-STAGE RENAL DISEASE WITH AND WITHOUT KIDNEY TRANSPLANTATION | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,559,912 | March 6, 2019 | February 28, 2029 | WEINBERG, ADRIANA | reporter.nih.gov |
| Platform for Extended Kidney Preservation Via Subnormothermic Perfusion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,527,840 | September 20, 2024 | December 31, 2026 | KOPPARTHY, VARUN LINGAIAH | reporter.nih.gov |
| Integrating a culturally competent APOL1 genetic testing program into living donor evaluation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,312,983 | April 1, 2021 | March 31, 2027 | AGRAWAL, AKANSHA | reporter.nih.gov |
| Role of Mitochondrial Dysfunction in the Response to Exercise in Patients with Advanced Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,263,477 | September 20, 2021 | July 31, 2027 | IKIZLER, TALAT ALP | reporter.nih.gov |
| Complement regulates macrophage and platelet function in kidney transplants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,127,980 | September 17, 2021 | August 31, 2026 | BALDWIN, WILLIAM M | reporter.nih.gov |
| Evaluation of the Mechanisms Underlying Induction and Maintenance Immunosuppression Impact on T Cell Function after Kidney Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,106,301 | July 16, 2025 | June 30, 2029 | SCHAENMAN, JOANNA M | reporter.nih.gov |
| NAVIGATE Kidney: A Multi-Level Intervention to Reduce Kidney Health Disparities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $3,050,402 | September 1, 2023 | June 30, 2028 | CERVANTES, LILIA | reporter.nih.gov |
| The Effects Of Telemedicine on Health Outcomes, Costs, and Perceptions of Care Delivery in In-Center Hemodialysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,038,882 | May 20, 2021 | April 30, 2027 | ERICKSON, KEVIN | reporter.nih.gov |
| Acute Antibody Mediated Kidney Allograft Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,037,635 | September 17, 2021 | August 31, 2026 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| Mechanisms of alloantibody production following renal transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,014,441 | February 22, 2021 | January 31, 2027 | VALUJSKIKH, ANNA | reporter.nih.gov |
| Multilevel Time-Dynamic Modeling of Hospitalization and Survival in Patients on Dialysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,964,247 | September 15, 2011 | February 28, 2027 | SENTURK, DAMLA | reporter.nih.gov |
| Kidney transplant Preemptive therapy or Prophylaxis (KPoP) for CMVPreventionin D+R- Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,952,999 | July 12, 2024 | May 31, 2031 | LIMAYE, ABHIJIT PRAKASH | reporter.nih.gov |
| Depleting autoantibodies for the treatment of autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,898,618 | March 11, 2022 | February 28, 2027 | KANNANGANAT SIDHARTHAN, SUNIL | reporter.nih.gov |
| Determinants of T Cell Fate in Transplantation Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,859,856 | August 1, 2022 | July 31, 2027 | FORD, MANDY L | reporter.nih.gov |
| Characterization of Renal Allograft Fibrosis and Prediction of Outcome Using a Quantitative MRI Approach | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,812,749 | July 8, 2021 | April 30, 2027 | LEWIS, SARA C | reporter.nih.gov |
| Manipulating the matrix to improve arteriovenous fistula patency | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,808,984 | September 1, 2019 | August 2, 2025 | DARDIK, ALAN | reporter.nih.gov |
| Kidney Support in Pediatric Patients using an Ultrafiltration Device | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,808,664 | May 18, 2021 | July 31, 2028 | KNUESEL, ROBERT J | reporter.nih.gov |
| Intradialytic Myocardial Stunning in Hemodialysis Patients - a Novel Cardiovascular Risk Factor | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,790,065 | December 24, 2021 | November 30, 2026 | CHARYTAN, DAVID M | reporter.nih.gov |
| Reaching Equity in ACess to Home Dialysis And Re-Transplantation (REACH-DART) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,785,676 | May 15, 2022 | February 28, 2027 | KU, ELAINE | reporter.nih.gov |
| The Vascular Fibroblast: An Understudied Culprit In Postoperative Venous Stenosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,777,206 | September 23, 2025 | August 31, 2029 | MARTINEZ, LAISEL | reporter.nih.gov |
| Blood Sugar Sensing on Maintenance Dialysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,740,674 | August 21, 2020 | May 31, 2030 | DE BOER, IAN H | reporter.nih.gov |
| INSPIRE: INterventionS for Promoting kIdney tRansplant Empowerment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,713,953 | September 1, 2023 | June 30, 2028 | CHAN, LILI | reporter.nih.gov |
| Causal connections between axon guidance proteins and early progressive kidney function decline in diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,713,884 | April 1, 2022 | January 31, 2027 | KROLEWSKI, ANDRZEJ S | reporter.nih.gov |
| Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,690,675 | June 18, 2021 | April 30, 2027 | KENDRICK, JESSICA B | reporter.nih.gov |
| Impact of Randomized Payment Incentives on Disparities in Home Dialysis and Kidney Transplantation | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,608,764 | February 9, 2022 | November 30, 2026 | TRIVEDI, AMAL N. | reporter.nih.gov |
| Chronic Antibody-Mediated Rejection of Kidney Allografts | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,566,057 | February 1, 2022 | January 31, 2027 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| MOVE Trial: MOtiVational Strategies to Empower African Americans to Improve Dialysis Adherence | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,557,446 | August 15, 2022 | May 31, 2027 | UMEUKEJE, EBELE M | reporter.nih.gov |
| Automatic Wide-Field Optical Coherence Tomography for Assessment of Transplant Kidney Viability | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,502,656 | September 15, 2022 | July 31, 2027 | ZHANG, XIAOHUI FRANK | reporter.nih.gov |
| TABA for SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,474,784 | April 15, 2020 | April 30, 2027 | BOIRE, TIMOTHY CHARLES | reporter.nih.gov |
| Organ banking for transplant--kidney cryopreservation by vitrification and novel nanowarming technology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,474,268 | April 13, 2018 | March 31, 2027 | FINGER, ERIK BRIAN | reporter.nih.gov |
| Cognitive Decline and Incident Dementia in Older Patients with Secondary Hyperparathyroidism | NIH | National Institute on Aging | 2023 to 2025 | $2,448,340 | February 15, 2023 | January 31, 2028 | MATHUR, AARTI | reporter.nih.gov |
| Improving Access to Nephrology Treatment and Care among Patients at Greatest Risk for Kidney Failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,442,134 | September 1, 2023 | June 30, 2028 | ARRIOLA, KIMBERLY RUTH JACOB | reporter.nih.gov |
| Virtually Supervised Exercise for Kidney Transplant Candidates | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,386,134 | September 15, 2022 | August 31, 2027 | LIU, CHRISTINE KEE | reporter.nih.gov |
| Access to Kidney Transplantation in Minority Populations (AKT-MP) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $2,384,015 | July 7, 2020 | January 31, 2026 | MYASKOVSKY, LARISSA | reporter.nih.gov |
| HLA Immunogenetics and kidney allograft outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,338,883 | November 21, 2022 | October 31, 2027 | KAMOUN, MALEK | reporter.nih.gov |
| The Synthetic Kidney: A Revolutionary Solution for the Shortage of Kidneys for Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,335,138 | September 15, 2022 | August 31, 2027 | LI, ZHONGWEI | reporter.nih.gov |
| Redefining cardiovascular risk assessment in dialysis patients (ROCK-D) study | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,274,042 | April 1, 2023 | March 31, 2028 | LIM, KENNETH | reporter.nih.gov |
| Delivery of an At-Home Nonpharmacologic Intervention (Transcranial Neurostimulation) to Mitigate Pain in Patients with End Stage Kidney Disease Receiving Hemodialysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,272,259 | December 1, 2021 | November 30, 2026 | REID, MANNEY CARRINGTON | reporter.nih.gov |
| Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,216,525 | September 1, 2024 | August 31, 2031 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Integration of Geriatric Care into Dialysis Clinics | NIH | National Institute on Aging | 2025 | $2,214,990 | September 1, 2023 | August 31, 2028 | HALL, RASHEEDA K | reporter.nih.gov |
| Deep learning on ECGs to improve outcomes in patients on dialysis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,181,958 | August 1, 2023 | May 31, 2028 | NADKARNI, GIRISH NITIN | reporter.nih.gov |
| NPHP2 in ciliary function, renal fibrosis and cyst formation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,168,386 | September 15, 2017 | April 30, 2027 | SUN, ZHAOXIA | reporter.nih.gov |
| Modulation of VSMC phenotype through the Insulin Receptor Substrate-1/Kruppel-like factor-4 signal transduction pathway: a Novel Target for AVF Dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,165,001 | May 1, 2022 | April 30, 2027 | XI, GANG | reporter.nih.gov |
| Innate Allorecognition in Clinical Organ Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,152,469 | December 20, 2022 | June 30, 2025 | LAKKIS, FADI G. | reporter.nih.gov |
| Non-APOL1 genetic factors and kidney transplant outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,142,442 | August 15, 2023 | May 31, 2028 | KIRYLUK, KRZYSZTOF | reporter.nih.gov |
| Thrombin-Mediated Podocyte Injury Mechanisms | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,133,362 | September 22, 2021 | June 30, 2027 | KERLIN, BRYCE ANDREW | reporter.nih.gov |
| Molecular Pathobiology of Alport Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,132,321 | September 15, 2022 | April 30, 2027 | HUDSON, BILLY GERALD | reporter.nih.gov |
| Monocyte chemoattractant Proteins and Vascular Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,102,067 | July 1, 2023 | April 30, 2027 | MISRA, SANJAY | reporter.nih.gov |
| Technology Assisted Collaborative Care Implementation Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,082,502 | July 5, 2017 | May 31, 2029 | JHAMB, MANISHA | reporter.nih.gov |
| Continuous allocation score design for guaranteeing equity and reducing discards in kidney and liver transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,022,974 | December 17, 2022 | November 30, 2027 | MASSIE, ALLAN B | reporter.nih.gov |
| The novel role of HLA-E restricted CD8 regulatory T cells in kidney allograft rejection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,004,858 | July 12, 2023 | June 30, 2028 | AZZI, JAMIL | reporter.nih.gov |
| REGULATORS OF CALCINEURIN PATHWAYS AS DIAGNOSTIC AND THERAPEUTIC TARGETS FOR NEPHROTIC SYNDROME | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,970,219 | February 1, 2023 | December 31, 2026 | GBADEGESIN, RASHEED ADEBAYO | reporter.nih.gov |
| Leveraging the ESRD Treatment Choices model to understand the benefits of home versus in-center dialysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,967,630 | July 1, 2023 | May 31, 2027 | SHAHINIAN, VAHAKN B | reporter.nih.gov |
| Racial disparities in access to kidney transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,967,199 | December 6, 2017 | March 31, 2029 | KU, ELAINE | reporter.nih.gov |
| Artificial Intelligence to Predict Outcomes in Patients with Acute Kidney Injury on Continuous Renal Replacement Therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,953,679 | April 1, 2023 | January 31, 2027 | NEYRA, JAVIER A. | reporter.nih.gov |
| VisR Ultrasound for Monitoring Antibody-Mediated Rejection in Renal Transplant Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,948,258 | March 1, 2016 | November 30, 2027 | GALLIPPI, CATERINA M | reporter.nih.gov |
| Improving Utilization of Live Donor Kidney Transplant through Effective Patient-Provider Communication | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,936,004 | June 5, 2023 | May 31, 2027 | SIMINOFF, LAURA A. | reporter.nih.gov |
| Donor Kidney Resident Macrophages in Kidney Allograft Early Inflammation and Alloimmunity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,919,356 | April 1, 2022 | February 28, 2027 | LUO, XUNRONG | reporter.nih.gov |
| Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,903,303 | July 19, 2022 | April 30, 2027 | BARBAS, ANDREW SERGHIOS | reporter.nih.gov |
| Dialyzing at home with a new model of the Wearable Artificial Kidney | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,867,003 | July 1, 2024 | May 31, 2026 | GURA, VICTOR | reporter.nih.gov |
| Role of myosin 1e in podocyte biology and renal filtration | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,857,244 | January 1, 2023 | November 30, 2026 | KRENDEL, MIRA | reporter.nih.gov |
| Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,835,791 | July 1, 2023 | May 31, 2028 | TABER, DAVID J. | reporter.nih.gov |
| The Gut Microbiome and Serum Metabolites as a Biological Mechanism Underlying Pain in Kidney Transplantation (Biome-KT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,824,012 | May 15, 2023 | February 29, 2028 | LOCKWOOD, MARK | reporter.nih.gov |
| Adaptive immunity regulates arteriovenous fistula remodeling | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,815,601 | December 12, 2022 | June 30, 2025 | DARDIK, ALAN | reporter.nih.gov |
| Therapeutic bubble tea: Preventing the formation of uremic toxins with hydrogel immobilized microbes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,772,161 | January 1, 2022 | December 31, 2026 | WINKLER, MARI-KAROLIINA | reporter.nih.gov |
| The Role of Vascular Calprotectin in Arteriovenous Fistula Maturation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,713,498 | May 1, 2022 | April 30, 2027 | VAZQUEZ PADRON, ROBERTO IRENARDO | reporter.nih.gov |
| Computational Image Analysis of Renal Transplant Biopsies to Predict Graft Outcome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,694,166 | September 6, 2023 | July 31, 2028 | SARDER, PINAKI | reporter.nih.gov |
| Role of LRP1 in Podocyte Biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,670,191 | September 27, 2012 | April 30, 2028 | ISHIBE, SHUTA | reporter.nih.gov |
| Immune repertoire remodeling following B cell-targeted CAR T cells for induction of renal allograft tolerance in non-human primates | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,648,086 | May 13, 2025 | April 30, 2030 | NAJI, ALI | reporter.nih.gov |
| Biodegradable Radiopaque Polymeric Scaffolds Loaded with Mesenchymal Stem Cells for Image-Guided Arteriovenous Fistula Maturation and Long-Term Patency | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,634,900 | April 15, 2022 | March 31, 2027 | MELANCON, MARITES PASUELO | reporter.nih.gov |
| Improving the patient experience of hemodialysis vascular access decision making | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,628,367 | September 1, 2022 | August 31, 2027 | WOO, KAREN | reporter.nih.gov |
| Optimizing Preimplantation Kidney Transplant Biopsy Interpretation with Artificial Intelligence Assistance - Resubmission - 1 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,626,699 | September 5, 2024 | June 30, 2029 | SEGEV, DORRY L. | reporter.nih.gov |
| Computational Drug Repositioning for Antibody Mediated Renal Allograft Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,614,752 | June 28, 2024 | April 30, 2029 | SARWAL, MINNIE M | reporter.nih.gov |
| Microbial Biomarkers for Diagnosing and Predicting Infections in Kidney Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,588,564 | May 24, 2024 | March 31, 2029 | LEE, JOHN RICHARD | reporter.nih.gov |
| Role of Intravenous ultrasound (IVUS) in arteriovenous hemodialysis access dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,583,229 | September 10, 2024 | June 30, 2029 | CHITALIA, VIPUL C | reporter.nih.gov |
| The RaDIANT Health Systems Intervention for Improving Access to Kidney Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,563,640 | July 1, 2023 | May 31, 2028 | PATZER, RACHEL E | reporter.nih.gov |
| Role of AMP-kinase pathway in the regulation of Minimal change disease-to-FSGS transition | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,555,769 | December 15, 2022 | November 30, 2027 | MENON, MADHAV C | reporter.nih.gov |
| TNFRSF13B polymorphisms and immunity to transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,533,577 | August 15, 2023 | July 31, 2028 | CASCALHO, MARILIA ISABEL | reporter.nih.gov |
| Pathobiology of autoimmune-mediated diffuse podocytopathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,504,974 | September 5, 2024 | May 31, 2029 | WEINS, ASTRID | reporter.nih.gov |
| Improving Kidney Transplant Outcomes and Reducing Costs of Care through Better Pretransplant Operations | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $1,500,424 | September 15, 2025 | August 31, 2029 | CHENG, XINGXING SHELLEY | reporter.nih.gov |
| PET Imaging of Renal Fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,447,749 | September 20, 2024 | June 30, 2029 | CARAVAN, PETER D | reporter.nih.gov |
| 12/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,441,669 | September 25, 2017 | May 31, 2028 | HSU, CHI-YUAN | reporter.nih.gov |
| APOM deficiency contributes to renal failure in glomerular diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,415,462 | July 1, 2023 | April 30, 2027 | FORNONI, ALESSIA | reporter.nih.gov |
| Interspecies microbial interactions in CKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,378,904 | May 15, 2024 | March 31, 2029 | BAUMLER, ANDREAS J | reporter.nih.gov |
| Comprehensive, Real-Time Monitoring of the Accumulation and Clearance of Small Molecules in Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,338,832 | May 15, 2024 | March 31, 2028 | KIPPIN, TOD EDWARD | reporter.nih.gov |
| Protection of donor kidney and transplanted graft function by modulating Na/K ATPase activity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,317,490 | April 1, 2024 | March 31, 2029 | LIU, RUISHENG | reporter.nih.gov |
| Assessment of Donor Quality for Improving Kidney Transplant Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,316,733 | February 1, 2017 | January 31, 2028 | MAS, VALERIA RAQUEL | reporter.nih.gov |
| Trans-omics Analysis of African American Deceased Donor Kidneys for Transplant Outcomes. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,304,338 | September 1, 2024 | June 30, 2028 | FREEDMAN, BARRY IRA | reporter.nih.gov |
| Systems analyses of induction and maintenance of immunity to SARS-CoV-2 vaccination in kidney transplant recipients receiving mycophenolate mofetil immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,264,269 | March 1, 2024 | February 28, 2029 | REED, ELAINE F | reporter.nih.gov |
| 7/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,262,779 | September 25, 2017 | May 31, 2028 | POGGIO, EMILIO DANIEL | reporter.nih.gov |
| Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,254,910 | December 16, 2023 | November 30, 2028 | KENDRICK, JESSICA B | reporter.nih.gov |
| Commercial and Regulatory Development of an Enhanced Performance Hemodialysis Access Graft | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,243,795 | April 15, 2024 | March 31, 2026 | MARSHALL, ANDREW | reporter.nih.gov |
| 8/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,223,386 | September 25, 2017 | May 31, 2028 | PASTAN, STEPHEN | reporter.nih.gov |
| Elucidating the Mechanisms of Racial and Ethnic Disparities in Dialysis Quality | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,203,001 | September 1, 2023 | June 30, 2028 | LIN, EUGENE | reporter.nih.gov |
| 4/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,202,677 | September 25, 2017 | May 31, 2028 | AGARWAL, GAURAV | reporter.nih.gov |
| 1-13 ApoL1 Genotypes in Kidney Donors and Long-Term Outcomes in Kidney Transplant Recipients Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,177,436 | September 25, 2017 | May 31, 2028 | FORNONI, ALESSIA | reporter.nih.gov |
| Vertically Integrated Approach to Design a Biologically and Mechanically Optimized Vascular Conduit for Dialysis Vascular Access | NIH | National Institute of Biomedical Imaging and Bioengineering | 2024 to 2025 | $1,115,881 | September 1, 2024 | May 31, 2028 | ROY-CHAUDHURY, PRABIR | reporter.nih.gov |
| Genetics and Immune Predictors for Recurrent Glomerular Diseases in the Kidney Allograft | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,096,846 | April 1, 2023 | January 31, 2028 | BATAL, IBRAHIM | reporter.nih.gov |
| Monocyte and Macrophage Functional Evolution in Kidney Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,091,998 | September 5, 2024 | June 30, 2029 | LUO, XUNRONG | reporter.nih.gov |
| Methods for the Analysis of Event Processes Arising in Organ Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,091,924 | September 15, 2005 | July 31, 2029 | SCHAUBEL, DOUGLAS EARL | reporter.nih.gov |
| Impact of ableism and state laws designed to mitigate ableism on organ transplant equity for kidney transplant candidates with intellectual or developmental disabilities | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,086,196 | August 1, 2024 | June 30, 2029 | HAND, BRITTANY NICOLE | reporter.nih.gov |
| 3/14 ApoL1 Long-Term Kidney Transplantation Outcomes Network (Apollo) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,081,955 | September 25, 2017 | May 31, 2028 | BRENNAN, DANIEL CONLON | reporter.nih.gov |
| Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,071,845 | September 25, 2017 | May 31, 2028 | BIRDWELL, KELLY A | reporter.nih.gov |
| Characterization of microvasculature in kidney transplant by super-resolution ultrasound imaging | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,044,664 | May 9, 2024 | March 31, 2029 | HUANG, CHENGWU | reporter.nih.gov |
| Safety and Efficacy of Empagliflozin Main intenance HD (SEED) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,035,601 | May 1, 2023 | April 30, 2027 | CHARYTAN, DAVID M | reporter.nih.gov |
| Evaluation of Angiopoietins as Prognostic Markers of Kidney Allograft Structure and Function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,035,280 | September 15, 2021 | May 31, 2027 | MANSOUR, SHERRY GEORGE | reporter.nih.gov |
| Sex Disparities in Cardiovascular Disease and Optimal Coronary Revascularization in Dialysis Patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,033,867 | May 7, 2021 | April 30, 2027 | SHAH, SILVI | reporter.nih.gov |
| Integrin Activation to Prevent Early Arteriovenous Fistula Failure in End-stage Renal Disease Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,027,600 | February 1, 2024 | January 31, 2028 | VAZQUEZ PADRON, ROBERTO IRENARDO | reporter.nih.gov |
| Community Health Workers in an Interdisciplinary Outpatient CKD Clinic to Optimize Social Care Navigation, Patient Engagement, and Home Dialysis Utilization- the CHOOSE Home trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,025,484 | August 1, 2024 | May 31, 2027 | JOHNS, TANYA | reporter.nih.gov |
| Macrovascular and Microvascular Response to Fluid Removal during Hemodialysis for Acute Kidney Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,020,421 | July 1, 2021 | April 30, 2026 | BROTMAN, CHRISTINA HAO WANG | reporter.nih.gov |
| 13/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,003,340 | September 25, 2017 | May 31, 2028 | REEVES-DANIEL, AMBER | reporter.nih.gov |
| Beyond Urea Kinetics: Balancing Tradeoffs in Dialyzer Design for the Next 50 Years | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $998,541 | August 16, 2024 | June 30, 2029 | WILSON, MATTHEW H | reporter.nih.gov |
| Development of a Treatment to Improve Arteriovenous Fistula Function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $997,033 | September 18, 2024 | July 31, 2026 | MILLER, AARON | reporter.nih.gov |
| Improving risk prediction of adverse outcomes in hemodialysis patients by incorporating non-traditional risk factors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $952,318 | January 15, 2021 | November 30, 2025 | CHAN, LILI | reporter.nih.gov |
| The Clinical Applications of the Difference in Estimated Glomerular Filtration Rate by Cystatin C vs. Creatinine (eGFRDiff) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $951,290 | July 1, 2021 | March 31, 2027 | POTOK, OLIVIA ALISON | reporter.nih.gov |
| 5/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $949,846 | September 25, 2017 | May 31, 2028 | MOHAN, SUMIT | reporter.nih.gov |
| Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $949,764 | September 15, 2021 | May 31, 2027 | EATON, CYD KUMIKO | reporter.nih.gov |
| Impact of Health-related Social Needs on Dialysis Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $945,496 | September 1, 2021 | May 31, 2026 | NOVICK, TESSA | reporter.nih.gov |
| CMV and CMV-Immune Responses in Geriatric Conditions Post-Kidney Transplant (CMV-GeriKT) | NIH | National Institute on Aging | 2021 to 2025 | $944,080 | August 15, 2021 | May 31, 2025 | ABIDI, MAHEEN ZEHRA | reporter.nih.gov |
| Comparing surgical and endovascular arteriovenous fistula creation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $933,134 | September 25, 2022 | August 31, 2026 | WOO, KAREN | reporter.nih.gov |
| Novel Mechanisms and Therapeutic Targets for Pulmonary Hypertension in End-Stage Renal Disease (K23) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $921,038 | August 1, 2021 | July 31, 2027 | EDMONSTON, DANIEL | reporter.nih.gov |
| Association of Dialysate Bicarbonate with Hemodynamic Instability and Arrhythmia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $909,256 | July 1, 2022 | June 29, 2027 | RAVI, KATHERINE SCOVNER | reporter.nih.gov |
| Transforming Curiosity into Donation: Validating a Risk Prediction Index to Detect and Prevent Drop-Out in Potential Living Kidney Donors who are Racial/Ethnic Minorities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $900,098 | September 1, 2023 | May 31, 2028 | WATERMAN, AMY DOGGETTE | reporter.nih.gov |
| 6/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $870,626 | November 2, 2023 | May 31, 2028 | DADHANIA, DARSHANA | reporter.nih.gov |
| Dialysate regeneration based on photo-electrochemical urea oxidation and reactive adsorption systems | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $853,604 | September 22, 2023 | June 30, 2027 | FULKERSON, BARRY | reporter.nih.gov |
| Individualized immunosuppression in organ transplant recipients based on real world evidence and artificial intelligence | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $847,371 | September 15, 2025 | July 31, 2030 | BAE, SUNJAE | reporter.nih.gov |
| The Landscape of Serious Infections following Kidney Transplantation in People Living with HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $846,608 | August 19, 2021 | July 31, 2026 | WERBEL, WILLIAM | reporter.nih.gov |
| Developing the Optimal Prehabilitation Program for Kidney Transplant Candidates on Hemodialysis - Resubmission - 1 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $842,633 | September 24, 2025 | July 31, 2030 | ORANDI, BABAK JOHN | reporter.nih.gov |
| Delineation of pathogenic mechanisms of NOS1AP and TRIM8 mutations in monogenic SRNS/FSGS. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $841,200 | July 1, 2021 | March 31, 2027 | MAJMUNDAR, AMAR J | reporter.nih.gov |
| Impact of Geographic Boundaries on Deceased Donor Kidney Discard, Allocation, and Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $837,981 | September 2, 2021 | July 31, 2026 | POTLURI, VISHNU SAGAR | reporter.nih.gov |
| Understanding Vision Impairment in ESKD to Prevent Cognitive Impairment and Dementia/Alzheimer’s disease: the VIS-HD Cohort Study | NIH | National Institute on Aging | 2025 | $829,211 | January 1, 2025 | December 31, 2029 | MCADAMS DEMARCO, MARA A. | reporter.nih.gov |
| Longitudinal Study of Quality of Everyday Life Experience among Home Dialysis Patients and Their Family Caregivers | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $818,481 | September 15, 2025 | July 31, 2030 | SONG, MI-KYUNG | reporter.nih.gov |
| Biopsychosocial Risk Factors for Psychiatric Disorders Following Kidney Transplantation | NIH | National Institute of Mental Health | 2022 to 2025 | $810,384 | August 1, 2022 | July 31, 2027 | NASH, REBEKAH POTTS | reporter.nih.gov |
| Patient provider communication and disparities in access to home dialysis and kidney transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $810,330 | September 4, 2025 | June 30, 2030 | KU, ELAINE | reporter.nih.gov |
| Virtual coaching for potential kidney transplant candidates and their social support networks | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $779,249 | March 15, 2023 | January 31, 2027 | HART, ALLYSON | reporter.nih.gov |
| Shared decision making for kidney transplant candidates to plan for an organ offer decision | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $777,072 | December 15, 2022 | November 30, 2026 | SCHAFFHAUSEN, CORY R | reporter.nih.gov |
| Identifying Behavioral Factors Contributing to High Discard Rate of Deceased Donor Kidneys | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $772,937 | March 15, 2024 | January 31, 2028 | GREEN, ELLEN P | reporter.nih.gov |
| Strengthening Shared Decision-Making for Older Adults with Kidney Failure Considering Kidney Transplant | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $744,620 | April 15, 2022 | February 28, 2027 | BUTLER, CATHERINE R | reporter.nih.gov |
| Contributions of Volume Overload Level and Ultrafiltration to Morbidity in ESKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $737,949 | September 24, 2025 | June 30, 2030 | DELGADO, CYNTHIA | reporter.nih.gov |
| Epigenetic Regulation of Regulatory B Cell Cytokine Expression and Allograft Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $727,129 | December 17, 2021 | November 30, 2026 | CHERUKURI, ARAVIND | reporter.nih.gov |
| IMPAKT Study: Imaging Modalities in Pediatric Assessments of Kidney Transplants | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $718,233 | July 15, 2022 | March 31, 2027 | VITERI BAQUERIZO, BERNARDA | reporter.nih.gov |
| 9/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $711,381 | September 25, 2017 | May 31, 2028 | ROSAS, SYLVIA E | reporter.nih.gov |
| Telemedicine for Evaluation and Counseling of Living Kidney Donor Candidates | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $706,133 | August 15, 2021 | May 31, 2027 | AL AMMARY, FAWAZ | reporter.nih.gov |
| An Image-Guided Microrobotic Drug Delivery Method for Preventive Vascular Interventions | NIH | National Heart, Lung, and Blood Institute | 2025 | $703,523 | May 21, 2025 | March 31, 2030 | CEYLAN, HAKAN | reporter.nih.gov |
| A clinical decision support tool to understand the survival benefit of kidney transplantation in candidates with a history of cancer | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $686,973 | September 5, 2024 | July 31, 2029 | HART, ALLYSON | reporter.nih.gov |
| Hospital-to-SNF Transitions of Care in Patients with End-Stage Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $685,605 | September 15, 2025 | August 31, 2030 | TUMMALAPALLI, SRI LEKHA | reporter.nih.gov |
| U Maryland Mid-Atlantic APOLLO Research Network Omic and Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $681,691 | September 25, 2017 | May 31, 2028 | BROMBERG, JONATHAN S | reporter.nih.gov |
| Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $650,235 | August 16, 2024 | June 30, 2027 | ASLAM, SAIMA | reporter.nih.gov |
| Determining Optimal Immunosuppression and Kidney Allocation Strategies for Mitigating Risks from Epstein-Barr Virus in Kidney Transplant Centers | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $644,770 | May 7, 2025 | April 30, 2030 | POTLURI, VISHNU SAGAR | reporter.nih.gov |
| Promoting Increases in Living Organ Donation via Tele-navigation (PILOT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $631,470 | March 15, 2025 | February 28, 2027 | SEGEV, DORRY L. | reporter.nih.gov |
| Prevention of Weight Gain and Impaired Glucose Metabolism Post Kidney Transplantation: A Pilot and Feasibility Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $620,000 | April 1, 2024 | March 31, 2027 | JAKICIC, JOHN M | reporter.nih.gov |
| Outcomes and perspectives on treatment for critical limb ischemia in patients with end-stage renal disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $611,222 | August 1, 2022 | July 31, 2027 | SHAH, SAMIR KAUSHIK | reporter.nih.gov |
| Addressing Inactive Kidney Transplant Waitlist Status through Adapting a Tailored Psycho-Social-Environmental Program | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $584,051 | May 1, 2023 | January 31, 2028 | HLADEK, MELISSA | reporter.nih.gov |
| Cognitive prehabilitation to prevent Alzheimer's disease after kidney transplantation | NIH | National Institute on Aging | 2023 to 2025 | $576,522 | December 1, 2022 | November 30, 2027 | MCADAMS DEMARCO, MARA A. | reporter.nih.gov |
| Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity 2 (CISTEM2) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $561,098 | February 1, 2025 | January 31, 2029 | DHARNIDHARKA, VIKAS R. | reporter.nih.gov |
| Comparative Safety and Efficacy of Low-dose Vitamin D in Kidney Failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $560,734 | August 1, 2023 | April 30, 2028 | HSU, SIMON | reporter.nih.gov |
| Antibody responses to chemical adducts in human kidney allograft rejection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $526,658 | September 26, 2016 | November 30, 2029 | ZORN, EMMANUEL | reporter.nih.gov |
| Implementation of Eplet Mismatch Analysis in Pediatric Kidney Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $522,724 | August 1, 2023 | May 31, 2027 | CHARNAYA, OLGA | reporter.nih.gov |
| Optimization and Validation of an AI Model that Screens for Arteriovenous Fistula Stenosis in Dialysis Patients using Sound Files from a Digital Stethoscope | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $503,966 | June 1, 2025 | May 31, 2029 | MOSADEGH, BOBAK | reporter.nih.gov |
| Precision medicine approaches to renal osteodystrophy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $500,152 | February 1, 2025 | June 30, 2027 | NICKOLAS, THOMAS L. | reporter.nih.gov |
| Innate allorecognition and KIR/LILR/HLA associations in kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $498,760 | August 22, 2025 | June 30, 2030 | LAKKIS, FADI G. | reporter.nih.gov |
| Individualized Immunosuppression for Kidney Transplant Recipients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $467,499 | May 22, 2023 | February 29, 2028 | BAE, SUNJAE | reporter.nih.gov |
| Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia (CONDOR) Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $467,239 | December 21, 2023 | January 31, 2027 | RHEE, CONNIE MEEYOUNG | reporter.nih.gov |
| The Role of Patient Capacity in Chronic Kidney Disease Trajectories | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $451,374 | August 24, 2023 | May 31, 2027 | BOEHMER, KASEY | reporter.nih.gov |
| Perfusion-based renal allograft modification to attenuate ischemia/reperfusion injury | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $441,522 | September 1, 2025 | August 31, 2027 | KANE, BOB R | reporter.nih.gov |
| Leveraging “Smart Stent” Platform Technologies for AVF Maturation and More | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $437,010 | September 11, 2025 | August 31, 2027 | ROY-CHAUDHURY, PRABIR | reporter.nih.gov |
| Quantifying and Predicting the Health Impacts of Wildfires and Extreme Heat Events Among End-Stage Kidney Disease Patients | NIH | National Institute of Environmental Health Sciences | 2025 | $417,272 | September 20, 2025 | September 19, 2027 | LIN, HUANG | reporter.nih.gov |
| Adaptive immunity regulates arteriovenous fistula remodeling | NIH | National Heart, Lung, and Blood Institute | 2025 | $415,084 | December 12, 2022 | November 30, 2026 | DARDIK, ALAN | reporter.nih.gov |
| MOBILIZE: Mobility & Transportation Solutions to Improve Hemodialysis Access | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $384,893 | September 1, 2024 | May 31, 2028 | RAZON, NA'AMAH | reporter.nih.gov |
| 1/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $381,503 | September 25, 2017 | May 31, 2028 | ASTOR, BRAD C | reporter.nih.gov |
| Cardiovascular and Renal Protection with SGLT2 Inhibition in Kidney Transplant Recipients (RENAISSANCE) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $380,466 | September 5, 2025 | May 31, 2027 | MATAS, ARTHUR J | reporter.nih.gov |
| Self-sealing needle guide system for reliable hemodialysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $379,836 | March 10, 2025 | November 30, 2025 | BOBE, JASON | reporter.nih.gov |
| Catheter-associated molecular patterns and arteriovenous fistula failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $364,563 | January 22, 2024 | April 30, 2025 | MARTINEZ, LAISEL | reporter.nih.gov |
| Promoting a Broad, Sustainable NIDDK-Supported Workforce through Mentoring Early Career Investigators: Focus on Health Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $358,683 | September 1, 2023 | August 31, 2028 | AMARAL, SANDRA | reporter.nih.gov |
| Patient-Centered Self-Cannulation Training Simulator to Promote Self-Care and Home Hemodialysis among African American Patients with Kidney Failure | NIH | National Institute on Minority Health and Health Disparities | 2025 | $349,859 | September 17, 2025 | September 18, 2026 | PETERSEN, LYDIA | reporter.nih.gov |
| The impact of antinuclear antibodies on alloimmune responses to renal transplants | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $332,690 | August 1, 2025 | July 31, 2027 | VALUJSKIKH, ANNA | reporter.nih.gov |
| Toward optimizing dialysis in the perioperative period | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $331,344 | July 22, 2024 | March 31, 2029 | FIELDING-SINGH, VIKRAM | reporter.nih.gov |
| A Remote Home-Based Rehabilitation Intervention for Kidney Transplant Candidates | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $330,997 | September 20, 2025 | June 30, 2028 | SCHRAUBEN, SARAH JEANNE | reporter.nih.gov |
| Comparative feasibility and effectiveness of medically tailored meals approaches for pediatric end stage kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $316,282 | September 9, 2025 | June 30, 2028 | DAVE, JAYNA MARKAND | reporter.nih.gov |
| AGT001 for Delayed Graft Function in Kidney Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $314,355 | September 15, 2025 | August 31, 2026 | BATLLE, DANIEL | reporter.nih.gov |
| Improved Dialysis Cannulation Needle | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $314,279 | September 12, 2025 | August 31, 2026 | BOLDENOW, PATRICK J | reporter.nih.gov |
| A new drug to treat transplant-associated renal ischemia-reperfusion injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $306,867 | August 1, 2025 | July 31, 2027 | SKIDGEL, RANDAL A | reporter.nih.gov |
| Bioinformatics pipeline for personalized diagnostics of transplant rejection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $306,500 | January 6, 2025 | December 31, 2026 | BARSKI, ARTEM | reporter.nih.gov |
| Quantifying peripheral blood antigen-specific memory B cells as a new biomarker in patients with PLA2R-associated membranous nephropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $304,993 | September 15, 2025 | August 31, 2026 | ZHU, QUANSHENG | reporter.nih.gov |
| Biodegradable and Elastic Vascular Grafts for Hemodialysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $298,371 | July 1, 2025 | June 30, 2027 | D'AMATO, ANTHONY | reporter.nih.gov |
| Predicting post-kidney transplant dementia/Alzheimer's Disease risk in older patients | NIH | National Institute on Aging | 2023 to 2025 | $281,428 | August 2, 2023 | August 1, 2026 | LONG, JANE J | reporter.nih.gov |
| A Hydrogen Sulfide Delivery Technology for Organ Preservation Therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $248,492 | September 15, 2025 | August 31, 2027 | SHEKARRIZ, REZA | reporter.nih.gov |
| Gout Epidemiology in Chronic Kidney Disease: Transition to End-stage Kidney Disease and Impact of Renal Transplant | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $240,715 | July 10, 2025 | May 31, 2028 | GAFFO, ANGELO L | reporter.nih.gov |
| Medicare's Kidney Care Choices Models: Participation and Nephrology Care Practice Reforms | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $237,750 | September 15, 2025 | August 31, 2027 | WILK, ADAM STEVEN | reporter.nih.gov |
| An adaptive, randomized controlled trial to treat BK polyomavirus infections (BKPyV) in pediatric kidney transplant recipients | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $235,500 | September 1, 2025 | August 31, 2026 | DHARNIDHARKA, VIKAS R. | reporter.nih.gov |
| Developing and establishing the content validity of a patient reported experience measure for the kidney transplant evaluation process | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $230,439 | September 1, 2025 | August 31, 2027 | BUTLER, CATHERINE R | reporter.nih.gov |
| Pharmaco-epidemiology of diabetes in patients with end-stage kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $230,250 | February 15, 2024 | November 30, 2026 | GALINDO, RODOLFO | reporter.nih.gov |
| Understanding Non-Clinical Donor Factors in Post-Donation Follow-Up to Improve Care for Living Kidney Donors: A Mixed Methods Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $229,553 | September 1, 2025 | August 31, 2027 | AL AMMARY, FAWAZ | reporter.nih.gov |
| A Social Determinants of Health Index for Transplant Access | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $222,750 | September 15, 2025 | August 31, 2027 | CANNON, ROBERT M. | reporter.nih.gov |
| Assessing the impact of cognitive biases on patient and provider willingness to accept imperfect kidneys for transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $193,652 | January 15, 2025 | November 30, 2029 | THIESSEN, CARRIE | reporter.nih.gov |
| Diagnosing disparities in existing and proposed allocation systems for kidney transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $191,500 | July 9, 2024 | July 8, 2027 | LIYANAGE, LUCKMINI | reporter.nih.gov |
| Optimizing Deceased Donor Kidney Allocation Using Decision Science | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $181,332 | August 1, 2022 | April 30, 2027 | HUSAIN, SYED ALI | reporter.nih.gov |
| Incentive Payments and Practice Patterns in Dialysis: The Case of Calcimimetics | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $171,896 | September 1, 2024 | August 31, 2026 | CALDWELL, JILLIAN SCOTT | reporter.nih.gov |
| A multi-omic investigation of uremic toxin sources and accumulation in children with kidney failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $171,639 | July 16, 2025 | March 31, 2030 | LEE, ARTHUR M | reporter.nih.gov |
| Leveraging a novel health records platform to predict the development of cardiovascular disease following kidney transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $169,706 | July 1, 2023 | June 30, 2026 | BOWRING, MARY GRACE | reporter.nih.gov |
| Project ANCHOR: A Small-Scale Pilot RCT of a Supportive Care Intervention for Caregivers of Patients Awaiting Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $165,899 | September 15, 2025 | July 31, 2030 | REED, RHIANNON DEIERHOI | reporter.nih.gov |
| Multi-level Factors that Influence Dialysis Facilities' Assessments of Patient Suitability for Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $146,963 | April 1, 2021 | February 28, 2027 | WILK, ADAM STEVEN | reporter.nih.gov |
| Volume And Patient-Oriented Research in Chronic Kidney Disease (VAPOR-CKD) | NIH | National Heart, Lung, and Blood Institute | 2025 | $131,886 | September 1, 2025 | August 31, 2030 | MCCAUSLAND, FINNIAN R | reporter.nih.gov |
| Identifying Facilitators and Barriers to Home Dialysis and Living Donor Kidney Transplantation among Adolescents and Young Adults | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $116,879 | April 1, 2024 | June 30, 2025 | BICKI, ALEXANDRA | reporter.nih.gov |
| The Influence of Symptoms, Functional Status, and Geographic Factors on Healthcare Use Among Patients Receiving Dialysis | NIH | National Institute of Nursing Research | 2024 to 2025 | $98,512 | March 1, 2024 | February 28, 2026 | NOORANI, NAZIYA P. | reporter.nih.gov |
| Noninvasive assessment of renal fibrosis in kidney transplant recipients bymulti-contrast magnetic resonance imaging | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $90,000 | March 1, 2025 | February 28, 2027 | STABINSKA, JULIA | reporter.nih.gov |
| Mechanisms of Renal Lipotoxicity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $85,712 | July 1, 2024 | June 30, 2027 | GABRIEL, KATLYN ROSE | reporter.nih.gov |
| End-Stage Kidney Disease in California's Central Valley: Investigating a Hotspot of Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $85,360 | September 1, 2025 | August 31, 2027 | CONTRERAS NIEVES, MARIMAR | reporter.nih.gov |
| Single Cell Analysis of Alloreactive CD8+ T Cells in Kidney Transplant Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $71,987 | November 22, 2022 | July 21, 2026 | SHI, TIFFANY | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of Pennsylvania | Philadelphia, PA | 9 | $30.5 million | 0 | $0 |
| Duke University | Durham, NC | 7 | $21.8 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 16 | $21.2 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 2 | $18.6 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 9 | $17 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 2 | $14.2 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 6 | $13.3 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 4 | $12.8 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 8 | $12.4 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 2 | $12.1 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 5 | $11.5 million | 0 | $0 |
| Yale University | New Haven, CT | 6 | $11.1 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 6 | $10.4 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 5 | $10 million | 0 | $0 |
| University of Washington | Seattle, WA | 6 | $9.8 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 2 | $9.7 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 5 | $9.1 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 7 | $8.7 million | 0 | $0 |
| University of Calgary | Calgary | 1 | $8.5 million | 0 | $0 |
| Emory University | Atlanta, GA | 5 | $7.4 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 4 | $7.4 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 5 | $6.5 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 2 | $6.1 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 5 | $5.9 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 3 | $5 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 4 | $4.7 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 4 | $4.6 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 4 | $4.2 million | 0 | $0 |
| Tufts Medical Center | Boston, MA | 1 | $4.2 million | 0 | $0 |
| Aronora, Inc. | Portland, OR | 1 | $3.8 million | 0 | $0 |
| Sonavex, Inc. | Baltimore, MD | 1 | $3.7 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 4 | $3.6 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 2 | $3.5 million | 0 | $0 |
| Biomedinnovations, Inc. | Denver, NC | 1 | $3.5 million | 0 | $0 |
| Joslin Diabetes Center | Boston, MA | 2 | $3.4 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 2 | $3.4 million | 0 | $0 |
| Astero Erado INC | College Station, TX | 1 | $2.9 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 2 | $2.9 million | 0 | $0 |
| Koronis Biomedical Technologies Corporat | Minneapolis, MN | 1 | $2.8 million | 0 | $0 |
| Brown University | Providence, RI | 1 | $2.6 million | 0 | $0 |
| Stanford University | Stanford, CA | 5 | $2.6 million | 0 | $0 |
| University of Massachusetts Amherst | Amherst, MA | 1 | $2.5 million | 0 | $0 |
| Venostent, Inc. | Houston, TX | 1 | $2.5 million | 0 | $0 |
| Palo Alto Veterans Instit for Research | Palo Alto, CA | 1 | $2.4 million | 0 | $0 |
| University of New Mexico Health Scis CTR | Albuquerque, NM | 1 | $2.4 million | 0 | $0 |
| University of Florida | Gainesville, FL | 2 | $2.3 million | 0 | $0 |
| Hennepin Healthcare Research Institute | Minneapolis, MN | 3 | $2.2 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 1 | $2.1 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 2 | $2 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 1 | $1.9 million | 0 | $0 |
| Wearable Artificial Organs, Inc. | Beverly Hills, CA | 1 | $1.9 million | 0 | $0 |
| Upstate Medical University | Syracuse, NY | 1 | $1.9 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 1 | $1.8 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 1 | $1.8 million | 0 | $0 |
| University of California at Davis | Davis, CA | 2 | $1.8 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 1 | $1.6 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 2 | $1.6 million | 0 | $0 |
| Boston Medical Center | Boston, MA | 1 | $1.6 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 1 | $1.5 million | 0 | $0 |
| University of California-Santa Barbara | Santa Barbara, CA | 1 | $1.3 million | 0 | $0 |
| University of South Florida | Tampa, FL | 1 | $1.3 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 3 | $1.2 million | 0 | $0 |
| Healionics Corporation | Seattle, WA | 1 | $1.2 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 2 | $1.1 million | 0 | $0 |
| Ohio State University | Columbus, OH | 1 | $1.1 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 1 | $1 million | 0 | $0 |
| Pavaj Vascular Corporation | Rochester, MN | 1 | $997,033 | 0 | $0 |
| University of Texas at Austin | Austin, TX | 1 | $945,496 | 0 | $0 |
| University of California-Irvine | Irvine, CA | 2 | $935,686 | 0 | $0 |
| Methodist Hospital Research Institute | Houston, TX | 1 | $900,098 | 0 | $0 |
| Kuleana Technology, Inc. | Seattle, WA | 1 | $853,604 | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 2 | $796,598 | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 1 | $772,937 | 0 | $0 |
| Mayo Clinic Arizona | Scottsdale, AZ | 1 | $703,523 | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 1 | $620,000 | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 2 | $575,155 | 0 | $0 |
| Washington University | Saint Louis, MO | 1 | $500,152 | 0 | $0 |
| Baylor University | Waco, TX | 1 | $441,522 | 0 | $0 |
| University of Maryland, College Park | College Park, MD | 1 | $417,272 | 0 | $0 |
| Flowpoint Medical INC | Overland Park, KS | 1 | $379,836 | 0 | $0 |
| Sojourn Medtech LLC | Pendleton, SC | 1 | $349,859 | 0 | $0 |
| Angiotensin Therapeutics, Inc. | Evanston, IL | 1 | $314,355 | 0 | $0 |
| Minnesota Healthsolutions Corporation | Saint Paul, MN | 1 | $314,279 | 0 | $0 |
| Dupage Medical Technology, Inc. | Chicago, IL | 1 | $306,867 | 0 | $0 |
| Datirium, LLC | Cincinnati, OH | 1 | $306,500 | 0 | $0 |
| Immunowork, LLC | Monrovia, CA | 1 | $304,993 | 0 | $0 |
| Anova Biomedical, Inc. | Ithaca, NY | 1 | $298,371 | 0 | $0 |
| Exhalix, LLC | Albuquerque, NM | 1 | $248,492 | 0 | $0 |
| Hugo W. Moser Res Inst Kennedy Krieger | Baltimore, MD | 1 | $90,000 | 0 | $0 |
| Broad Institute, Inc. | Cambridge, MA | 1 | $85,712 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 229 | $145,274,528 | 0 | $0 |
| 2024 | 167 | $101,240,059 | 0 | $0 |
| 2023 | 130 | $81,774,315 | 0 | $0 |
| 2022 | 82 | $53,653,307 | 0 | $0 |
| 2021 | 45 | $32,152,125 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.